Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 5, 2010, Pages 876-887

  Pränting, Maria ^a   Andersson, Dan I ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Antimicrobial peptides; Fitness costs; Haem biosynthesis; Small colony variants

Indexed keywords

AMPICILLIN; BLEOMYCIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CATHELICIDIN RELATED ANTIMICROBIAL PEPTIDE; CHLORAMPHENICOL; CIPROFLOXACIN; CNY 100; COLISTIN; DEFENSIN; DEFENSIN 1; GENTAMICIN; HEMIN; LACTOFERRICIN; NITROFURANTOIN; POLYPEPTIDE ANTIBIOTIC AGENT; PR 39; PROTAMINE SULFATE; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; PROTAMINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM MUTANT; BIOSYNTHESIS; CELL RESPIRATION; CONTROLLED STUDY; DNA SEQUENCE; EPSILOMETER TEST; FRAMESHIFT MUTATION; GENE INSERTION; GENE MAPPING; GENOTYPE; GROWTH RATE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; MUTATION RATE; NONHUMAN; SALMONELLA TYPHIMURIUM; SCREENING; SEROTYPE; TRANSPOSON; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MICROBIOLOGICAL EXAMINATION; MUTATION; NUCLEOTIDE SEQUENCE; VIRUS CULTURE;

ANTI-BACTERIAL AGENTS; DNA MUTATIONAL ANALYSIS; DNA TRANSPOSABLE ELEMENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTAGENESIS, INSERTIONAL; MUTATION; PROTAMINES; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE;

EID: 77953718200     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq059     Document Type: Article

References (51)

1. Gennaro R, Zanetti M, Benincasa M et al. Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr Pharm Des 2002; 8: 763-78.
2. Yang D, Biragyn A, Hoover DM et al. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu Rev Immunol 2004; 22: 181-215.
3. Bell G, Gouyon PH. Arming the enemy: the evolution of resistance to self-proteins. Microbiology 2003; 149: 1367-75.
4. Bals R, Wang X, Wu Z et al. Human b-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998; 102: 874-80.
5. Bowdish DM, Davidson DJ, Lau YE et al. Impact of LL-37 on anti-infective immunity. J Leukoc Biol 2005; 77: 451-9.
6. Dhawan VK, Yeaman MR, Cheung AL et al. Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun 1997; 65: 3293-9.
7. Hansen LT, Gill TA. Solubility and antimicrobial efficacy of protamine on Listeria monocytogenes and Escherichia coli as influenced by pH. J Appl Microbiol 2000; 88: 1049-55.
8. Islam NMD, Itakura T, Motohiro T. Antibacterial spectra and minimum inhibition concentration of clupeine and salmine. Bull Jpn Soc Sci Fish 1984; 50: 1705-8.
9. Johansen C, Gill T, Gram L. Antibacterial effect of protamine assayed by impedimetry. J Appl Bacteriol 1995; 78: 297-303.
10. Kamal M, Motohiro T. Effect of pH and metal ions on the fungicidal action of salmine sulfate. Bull Jpn Soc Sci Fish 1986; 52: 1843-6.
11. Uyttendaele M, Debevere J. Evaluation of the antimicrobial activity of protamine Food Microbiol 1994; 11: 417-27.
12. Groisman EA, Parra-Lopez C, Salcedo M et al. Resistance to host antimicrobial peptides is necessary for Salmonella virulence. Proc Natl Acad Sci USA 1992; 89: 11939-43.
13. Bayer AS, McNamara P, Yeaman MR et al. Transposon disruption of the complex I NADH oxidoreductase gene (snoD) in Staphylococcus aureus is associated with reduced susceptibility to the microbicidal activity of thrombin-induced platelet microbicidal protein 1. J Bacteriol 2006; 188: 211-22.
14. Koo SP, Bayer AS, Yeaman MR. Diversity in antistaphylococcal mechanisms among membrane-targeting antimicrobial peptides. Infect Immun 2001; 69: 4916-22.
15. Yeaman MR, Soldan SS, Ghannoum MA et al. Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun 1996; 64: 1379-84.
16. Sadowska B, Bonar A, von Eiff C et al. Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants. FEMS Immunol Med Microbiol 2002; 32: 191-7.
17. Proctor RA, von Eiff C, Kahl BC et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol 2006; 4: 295-305.
18. Banky JP, Ostergaard L, Spelman D. Chronic relapsing Salmonella osteomyelitis in an immunocompetent patient: case report and literature review. J Infect 2002; 44: 44-7.
19. von Eiff C, Peters G, Becker K. The small colony variant (SCV) concept-the role of staphylococcal SCVs in persistent infections. Injury 2006; 37 Suppl 2: S26-33.
20. Cano DA, Pucciarelli MG, Martinez-Moya M et al. Selection of small-colony variants of Salmonella enterica serovar Typhimurium in nonphagocytic eucaryotic cells. Infect Immun 2003; 71: 3690-8.
21. Rosche WA, Foster PL. Determining mutation rates in bacterial populations. Methods 2000; 20: 4-17.
22. Janzer JJ, Stan-Lotter H, Sanderson KE. Isolation and characterization of hemin-permeable, envelope-defective mutants of Salmonella typhimurium. Can J Microbiol 1981; 27: 226-37.
23. Hecht SM. Bleomycin: new perspectives on the mechanism of action. J Nat Prod 2000; 63: 158-68.
24. Pasupuleti M, Walse B, Svensson B et al. Rational design of antimicrobial C3a analogues with enhanced effects against staphylococci using an integrated structure and function-based approach. Biochemistry 2008; 47: 9057-70.
25. Boman HG, Agerberth B, Boman A. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 1993; 61: 2978-84.
26. Gallo RL, Kim KJ, Bernfield M et al. Identification of CRAMP, a cathelin-related antimicrobial peptide expressed in the embryonic and adult mouse. J Biol Chem 1997; 272: 13088-93.
27. Gudmundsson GH, Agerberth B, Odeberg J et al. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996; 238: 325-32.
28. Termen S, Tollin M, Olsson B et al. Phylogeny, processing and expression of the rat cathelicidin rCRAMP: a model for innate antimicrobial peptides. Cell Mol Life Sci 2003; 60: 536-49.
29. Bellamy W, Takase M, Wakabayashi H et al. Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. J Appl Bacteriol 1992; 73: 472-9.
30. Ganz T, Selsted ME, Szklarek D et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-35.
31. Frankenberg N, Moser J, Jahn D. Bacterial heme biosynthesis and its biotechnological application. Appl Microbiol Biotechnol 2003; 63: 115-27.
32. Pittman MS, Corker H, Wu G et al. Cysteine is exported from the Escherichia coli cytoplasm by CydDC, an ATP-binding cassette-type transporter required for cytochrome assembly. J Biol Chem 2002; 277: 49841-9.
33. Pittman MS, Robinson HC, Poole RK. A bacterial glutathione transporter (Escherichia coli CydDC) exports reductant to the periplasm. J Biol Chem 2005; 280: 32254-61.
34. Stroupe ME, Leech HK, Daniels DS et al. CysG structure reveals tetrapyrrole-binding features and novel regulation of siroheme biosynthesis. Nat Struct Biol 2003; 10: 1064-73.
35. Elliott T, Roth JR. Heme-deficient mutants of Salmonella typhimurium: two genes required for ALA synthesis. Mol Gen Genet 1989; 216: 303-14.
36. Wang LY, Brown L, Elliott M et al. Regulation of heme biosynthesis in Salmonella typhimurium: activity of glutamyl-tRNA reductase (HemA) is greatly elevated during heme limitation by a mechanism which increases abundance of the protein. J Bacteriol 1997; 179: 2907-14.
37. Proctor RA, Kahl B, von Eiff C et al. Staphylococcal small colony variants have novel mechanisms for antibiotic resistance. Clin Infect Dis 1998; 27 Suppl 1: S68-74.
38. Baumert N, von Eiff C, Schaaff F et al. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 2002; 8: 253-60.
39. Miller MH, Edberg SC, Mandel LJ et al. Gentamicin uptake in wild-type and aminoglycoside-resistant small-colony mutants of Staphylococcus aureus. Antimicrob Agents Chemother 1980; 18: 722-9.
40. Aspedon A, Groisman EA. The antibacterial action of protamine: evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium. Microbiology 1996; 142: 3389-97.
41. Johansen C, Verheul A, Gram L et al. Protamine-induced permeabilization of cell envelopes of gram-positive and gram-negative bacteria. Appl Environ Microbiol 1997; 63: 1155-9.
42. Stumpe S, Bakker EP. Requirement of a large K+-uptake capacity and of extracytoplasmic protease activity for protamine resistance of Escherichia coli. Arch Microbiol 1997; 167: 126-36.
43. Claiborne A, Fridovich I. Purification of the o-dianisidine peroxidase from Escherichia coli B. Physicochemical characterization and analysis of its dual catalatic and peroxidatic activities. J Biol Chem 1979; 254: 4245-52.
44. Goldman BS, Gabbert KK, Kranz RG. Use of heme reporters for studies of cytochrome biosynthesis and heme transport. J Bacteriol 1996; 178: 6338-47.
45. Hoober JK, Kahn A, Ash DE et al. Biosynthesis of delta-aminolevulinate in greening barley leaves. IX. Structure of the substrate, mode of gabaculine inhibition, and the catalytic mechanism of glutamate 1-semialdehyde aminotransferase. Carlsberg Res Commun 1988; 53: 11-25.
46. von Eiff C, Heilmann C, Proctor RA et al. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J Bacteriol 1997; 179: 4706-12.
47. Norstrom T, Lannergard J, Hughes D. Genetic and phenotypic identification of fusidic acid-resistant mutants with the small-colonyvariant phenotype in Staphylococcus aureus. Antimicrob Agents Chemother 2007; 51: 4438-46.
48. Falagas ME, Kasiakou SK. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 2005; 40: 1333-41.
49. Samuelsen O, Haukland HH, Kahl BC et al. Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. J Antimicrob Chemother 2005; 56: 1126-9.
50. Anderson P, Roth J. Spontaneous tandem genetic duplications in Salmonella typhimurium arise by unequal recombination between rRNA (rrn) cistrons. Proc Natl Acad Sci USA 1981; 78: 3113-7.
51. Nilsson AI, Zorzet A, Kanth A et al. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc Natl Acad Sci USA 2006; 103: 6976-81.